PERSPECTA

News from every angle

← Back to headlines

AtaiBeckley (ATAI) to Initiate Phase 3 Depression Study Following Positive FDA Meeting

4 Mar, 16:40 — 4 Mar, 16:40
PostShare
Only 1 source covers this story